Michael Lee

HCRN-GI17-319

A single arm, multi-center Phase 2 trial of mFOLFOX6 + trastuzumab + avelumab in first-line, metastatic, HER2-amplified gastric and esophageal adenocarcinoma  
Status
Closed
Cancer Types
Gastric
Locations